Capricorn Partners

Capricorn Partners, established in 1993, is a Belgium-based asset management firm specializing in venture capital. It invests in innovative European companies that leverage technology for a competitive edge, focusing on sectors such as information technology, healthcare, and clean technology. The firm's investment team comprises experienced professionals with deep technology expertise and broad industrial experience.

Jan Avonts

Investment Director

Damien van der Bijl

Investment Director

Damien van der Bijl

Investment Director

Daniela Arruda Costa

Investment Associate

Olaf Corper

Partner

Paul Decraemer

Partner

Antoine D’Hollander

Investment Director

Katrin Geyskens

Partner, Member of the Executive Committee and Board Member

Steven Lambert

Investment Partner Digital

Steven Lambert

Investment Partner Digital

Marc Lambrechts Ph.D

Investment Director

Steven Levecke

Partner

Jos B. Peeters

Founding Partner

Filip Pintelon

Investment Partner Health

Wouter Van de Putte

Investment Director

Ekaterina Smirnyagina

Partner

Claude Stoufs

Partner

Yves Vaneerdewegh

Partner, Member of the Executive Committee and Board Member

Sabine Vermassen

Partner, Member of the Executive Committee and Board Member

Simon Wouters

Investment Analyst

Ke Zhang

Investment Director

103 past transactions

Gradyent

Series B in 2025
Gradyent is an AI cloud platform based in Utrecht, The Netherlands, founded in 2019. It specializes in optimizing heating systems for district heating companies, effectively reducing CO2 emissions and improving energy efficiency. Utilizing Digital Twin technology, Gradyent creates a digital replica of physical heating systems by integrating geographical, weather, and sensor data with physical models and artificial intelligence. This innovative approach allows real-time optimization of heating systems, enabling users to simulate future scenarios and make informed decisions. As a result, clients experience significant savings, with an average reduction of 20% in heat loss, 10% in CO2 emissions, and 5-10% in fuel costs. Gradyent's platform also offers dynamic forecasting and the capability to monitor network status, making it accessible for clients to securely manage their networks from anywhere at any time.

InsectSense

Pre Seed Round in 2025
InsectSense is a biotechnology firm focused on developing innovative solutions inspired by the natural sensory mechanisms of insects. Recognizing the advanced capabilities that have evolved over millions of years, the company aims to harness these biological insights to address significant global challenges. InsectSense's technology enables precise detection and measurement of low-concentration compounds, facilitating accurate diagnosis of novel diseases by allowing physicians to identify the unique "fingerprints" of volatile compounds from complex sample mixtures. Through its work, InsectSense seeks to create positive societal and environmental impacts worldwide by leveraging the inherent potential of insect-inspired sensing systems.

Minze Health

Series A in 2024
Minze Health is a Belgian healthtech startup founded in 2015 and headquartered in Antwerp. The company specializes in developing digital health solutions aimed at addressing urinary tract issues, particularly focusing on urologic, pelvic health, and continence care. Its innovative platform supports the diagnostic, treatment, and remote patient monitoring of individuals experiencing lower urinary tract symptoms (LUTS). Minze Health's solutions are utilized by hospitals, urology practices, and pelvic floor rehabilitation centers globally, enabling healthcare providers to effectively diagnose and monitor patients both in clinical settings and private practices.

Econic Technologies

Venture Round in 2024
Econic Technologies Ltd. is a chemical technology company based in Macclesfield, United Kingdom, specializing in the development of innovative processes to convert carbon dioxide and epoxides into valuable polymers and polyurethanes. Founded in 2011, the company leverages catalyst chemistry to transform waste CO2 into commercially viable products, thereby reducing dependence on fossil fuels and providing environmental benefits. Econic's product offerings include polycarbonates and polycarbonate polyols, which are utilized in various applications such as mattresses, insulation, footwear, packaging, and construction materials. Additionally, the company produces glues and coatings for industrial uses. With patented catalyst technologies and a skilled team of scientists and engineers, Econic Technologies operates from a state-of-the-art facility at Alderley Park, focusing on turning scientific advancements into practical solutions for the plastics industry while addressing environmental challenges.

Thryve

Series A in 2024
Thryve is a developer of a data and wearable application programming interface platform that facilitates access to fragmented health data from various medical devices and wearables. The company's software development kit (SDK) allows for seamless integration of health information from sources such as smartwatches and blood glucose meters, enabling users to harmonize their health data into a continuous stream of information. By supporting popular platforms like Apple Health, Google Fit, Huawei Health, and Samsung Health, Thryve empowers insurers, researchers, and developers to access real-time health sensor data. This integration enhances their ability to deliver personalized interventions and improve service offerings through the utilization of comprehensive health information.

NEFFA

Seed Round in 2024
NEFFA is a pioneering fashion technology company dedicated to revolutionizing the industry's environmental impact. It specializes in developing fully automated, sustainable production methods for custom-fit, vegan textiles. NEFFA's innovative 3D design interface allows for rapid application of various textures, while its unique manufacturing process creates affordable and recyclable molds without high heat or pressure. Currently focusing on mycelium-based MycoTEX material, NEFFA aims to reduce waste and enable profitable, eco-friendly clothing production.

Chainels

Series A in 2023
Chainels is a comprehensive tenant experience platform that focuses on enhancing the management of multi-tenant environments such as shopping centers, mixed-use developments, transport hubs, offices, and residential buildings. Based in Rotterdam, the company serves over 400 communities, encompassing around 50,000 companies and households across multiple countries. Chainels aims to digitalize operations and foster a sense of community by providing an intuitive app that facilitates communication, amenities management, data reporting, and marketing efforts. By streamlining property management processes through features like direct communication channels and an efficient ticketing system, Chainels empowers stakeholders to improve tenant engagement and retention. Their client base includes prominent organizations such as Multi Corporation, Amvest/Fuzer, and CBRE, highlighting their significant presence in the property management sector.

Fruitcore Robotics

Series B in 2022
Fruitcore Robotics specializes in the design and development of robotic systems aimed at automating industrial processes. The company utilizes advanced software and innovative mechatronics to create optimized robotic solutions. Its technology is applicable in various industrial contexts, encompassing tasks such as workpiece handling, fitting, assembling, screwing, palletizing, stacking, packaging, and workpiece testing. By implementing these robotic systems, Fruitcore Robotics enables manufacturers to enhance operational efficiency while reducing both time and costs associated with production tasks.

Trillium Renewable Chemicals

Series A in 2022
Trillium Renewable Chemicals, founded in 2021 and based in Knoxville, Tennessee, specializes in the manufacture of chemicals derived from renewable feedstocks. The company focuses on producing acrylic molecules and glycols, offering industrial clients a sustainable alternative to fossil-based acrylonitrile. By utilizing renewable resources such as glycerol, Trillium aims to provide a secure supply of renewable chemicals that not only reduce carbon emissions but also enhance safety and economic stability. This approach positions Trillium as a forward-thinking player in the renewable chemicals sector, catering to the growing demand for environmentally friendly industrial solutions.

Minze Health

Seed Round in 2022
Minze Health is a Belgian healthtech startup founded in 2015 and headquartered in Antwerp. The company specializes in developing digital health solutions aimed at addressing urinary tract issues, particularly focusing on urologic, pelvic health, and continence care. Its innovative platform supports the diagnostic, treatment, and remote patient monitoring of individuals experiencing lower urinary tract symptoms (LUTS). Minze Health's solutions are utilized by hospitals, urology practices, and pelvic floor rehabilitation centers globally, enabling healthcare providers to effectively diagnose and monitor patients both in clinical settings and private practices.

neotiv

Seed Round in 2022
Neotiv GmbH is a German company founded in 2017 and headquartered in Magdeburg, specializing in the development of mobile software aimed at monitoring and enhancing memory functions. The company creates digital solutions that facilitate the early detection and ongoing tracking of memory problems, particularly those associated with aging and early stages of Alzheimer’s disease. Neotiv's offerings include memory tests that focus on brain regions affected by cognitive decline, while also providing insights derived from scientific research to support users in managing their cognitive health. The application is designed not only for individual users but also serves as a valuable tool for healthcare professionals and drug developers, enabling them to monitor psychological effects and assist patients with dementia.

Xanadu

Series C in 2022
Xanadu, founded in 2016, is a company dedicated to advancing quantum computing technology, focusing on its societal implications and practical applications. The organization aims to provide quantum computing on demand, achieving significant computational enhancements beyond classical methods for complex real-world challenges. Xanadu operates a quantum photonic platform that integrates quantum silicon photonic chips with existing hardware, creating a comprehensive quantum computing solution. By combining the expertise of leading scientists with industry professionals, Xanadu seeks to develop scalable quantum technologies that are accessible to a wide range of users, enabling them to address various business problems efficiently.

Bingli

Series A in 2022
Bingli is a healthcare technology company that specializes in developing applications aimed at improving communication between patients and doctors. The company's application conducts smart pre-consultation interviews with patients, enabling them to accurately convey their symptoms to healthcare providers. This process ensures that patients are better prepared for their consultations, while also allowing doctors to save time during appointments. By facilitating more effective information sharing, Bingli aims to enhance the overall quality of healthcare delivery.

Gradyent

Series A in 2022
Gradyent is an AI cloud platform based in Utrecht, The Netherlands, founded in 2019. It specializes in optimizing heating systems for district heating companies, effectively reducing CO2 emissions and improving energy efficiency. Utilizing Digital Twin technology, Gradyent creates a digital replica of physical heating systems by integrating geographical, weather, and sensor data with physical models and artificial intelligence. This innovative approach allows real-time optimization of heating systems, enabling users to simulate future scenarios and make informed decisions. As a result, clients experience significant savings, with an average reduction of 20% in heat loss, 10% in CO2 emissions, and 5-10% in fuel costs. Gradyent's platform also offers dynamic forecasting and the capability to monitor network status, making it accessible for clients to securely manage their networks from anywhere at any time.

StoryChief

Venture Round in 2022
StoryChief is a content marketing software designed to assist businesses in enhancing their content reach by centralizing content creation and distribution processes. The platform enables users, including startups, SEO marketers, and editorial teams, to publish articles across multiple channels swiftly. With its universal editor, StoryChief allows users to create visually appealing stories that are optimized for various platforms such as WordPress, Medium, and numerous social media channels. Additionally, the software offers performance tracking, SEO suggestions, and lead capture capabilities, facilitating a comprehensive approach to content marketing. By providing a streamlined solution for content distribution, StoryChief empowers users to measure their impact and return on investment effectively.

Finquest

Seed Round in 2022
Finquest is a leading deal origination provider that specializes in delivering personalized connections for clients seeking mergers and acquisitions (M&A) and direct investment opportunities across Europe, North America, and the Asia-Pacific region. Utilizing a unique database and advanced machine learning techniques, Finquest offers targeted and curated introductions, facilitating a more efficient deal-making process while ensuring complete confidentiality. The company's platform focuses on the middle market, connecting institutional investors with potential investment opportunities and enabling corporate buyers to identify relevant acquirers. Headquartered in Singapore, Finquest operates offices in key financial centers including New York, Dallas, London, Paris, Frankfurt, Luxembourg, Bangalore, and Hong Kong, broadening market access for its clients.

VoxelSensors

Seed Round in 2022
VoxelSensors is a technology company specializing in advanced sensing solutions for spatial and empathic interfaces, targeting mobile, XR, and industrial applications. The company has developed proprietary Single Photon Active Event Sensor (SPAES) technology, which leverages Single-Photon Avalanche Diodes (SPADs) to create low-power, low-latency data pathways. This innovative system enables precise spatial awareness, gaze tracking, and intuitive interactions, meeting the needs of manufacturers in the consumer electronics sector. VoxelSensors’ products represent a new category of three-dimensional perception systems, capable of capturing data with minimal photon usage. By enhancing immersive and autonomous experiences, VoxelSensors significantly contributes to the growth of the Mobile and XR markets while addressing the increasing demand for sophisticated spatial and empathic applications across various industries.

Zozio

Seed Round in 2022
Zozio is a logistics platform designed to optimize factory operations by collecting, visualizing, and analyzing field data in real-time both inside and outside the factory. The company's digital companion, powered by AI algorithms, aims to transform industrial work environments into Factory 4.0 setups. By doing so, Zozio relieves technical operators of manual, repetitive tasks and assists operational managers in making informed logistical planning decisions. This approach enhances factory efficiency, improves working conditions for operators, minimizes resource waste, and helps manufacturers improve their competitiveness on a global scale.

Econic Technologies

Series D in 2022
Econic Technologies Ltd. is a chemical technology company based in Macclesfield, United Kingdom, specializing in the development of innovative processes to convert carbon dioxide and epoxides into valuable polymers and polyurethanes. Founded in 2011, the company leverages catalyst chemistry to transform waste CO2 into commercially viable products, thereby reducing dependence on fossil fuels and providing environmental benefits. Econic's product offerings include polycarbonates and polycarbonate polyols, which are utilized in various applications such as mattresses, insulation, footwear, packaging, and construction materials. Additionally, the company produces glues and coatings for industrial uses. With patented catalyst technologies and a skilled team of scientists and engineers, Econic Technologies operates from a state-of-the-art facility at Alderley Park, focusing on turning scientific advancements into practical solutions for the plastics industry while addressing environmental challenges.

DMC Biotechnologies

Series B in 2021
DMC Biotechnologies, Inc. is a biotechnology company based in Boulder, Colorado, that specializes in the development of bio-based products through microbial fermentation technology. Founded in 2014, the company focuses on engineering microbial hosts to produce a range of specialty chemicals, flavors, fragrances, nutraceuticals, natural products, and pharmaceuticals. DMC Biotechnologies employs its proprietary Dynamic Metabolic Control technology to enhance production efficiency, thereby reducing costs and accelerating the timeline from discovery to commercial performance. The company's innovative approach supports sustainability by utilizing lower energy and resource inputs in the manufacturing process.

Qpinch

Series B in 2021
Qpinch is a company focused on transforming wasted industrial heat into valuable process heat, thereby generating carbon-neutral steam and reducing energy costs for various industries. By utilizing an innovative chemical heat transformer, Qpinch helps businesses optimize their existing industrial assets, leading to immediate energy savings while minimizing their environmental impact. The company's technology allows clients to effectively repurpose waste heat, contributing to a more sustainable energy landscape and enhancing operational efficiency.

Black Bear Carbon

Venture Round in 2021
Black Bear Carbon BV specializes in the conversion of waste tires into carbon black and green energy, operating from its base in Nederweert, the Netherlands, since its founding in 2010. The company utilizes a circular economy model, transforming end-of-life tires into sustainable products that serve various industries. Its carbon black, derived from controlled pyrolysis and partial combustion of hydrocarbons, is utilized in applications such as tires, technical rubber products, plastics, paints, and inks. In addition to producing carbon black, Black Bear Carbon generates electricity from its operations, which powers its tire shredding processes and supplies energy to local industries and grids. Through these efforts, the company provides businesses with recyclable carbon compounds, contributing to reduced reliance on oil and lower carbon dioxide emissions.

EclecticIQ

Series C in 2020
EclecticIQ is a company specializing in threat intelligence and cybersecurity solutions. It develops advanced technology for threat hunting and response, aimed at enhancing organizations' defenses against cyber adversaries. The company's platform integrates and interprets intelligence data sourced from open sources, commercial suppliers, and industry partnerships. This enables enterprises to bolster their detection, prevention, and response capabilities by embedding actionable intelligence into their cybersecurity infrastructures. Through its offerings, EclecticIQ strives to empower organizations to effectively combat evolving cyber threats.

Sensolus

Venture Round in 2020
Sensolus NV specializes in the design and development of GPS trackers for non-powered assets, offering comprehensive solutions for tracking and monitoring these items through advanced wireless technology. Founded in 2013 and based in Ghent, Belgium, the company combines expertise in low-power networks and wireless sensor design to deliver innovative tracking systems, including their personal product line, STICKNTRACK. Sensolus provides a cloud-based platform that enables users to access real-time information about their assets, making the management of valuable equipment in industries such as manufacturing, waste management, cargo transport, logistics, and automotive efficient and straightforward. Their offerings focus on affordable, easy-to-install, and maintenance-free tracking solutions, ensuring seamless asset management for users.

Innovium

Series F in 2020
Innovium, Inc. is a technology company that develops and deploys advanced switching silicon solutions tailored for cloud, enterprise, and edge data centers globally. Founded in 2014 and headquartered in San Jose, California, with an additional location in Bengaluru, India, Innovium focuses on addressing the critical challenges faced by modern data centers. The company offers its TERALYNX product line, including TERALYNX 7 for large-scale public and private clouds and TERALYNX 5 for top-of-rack, enterprise, edge, and 5G data centers. Additionally, Innovium provides a cloud-based network operating system, open-source standard APIs, and a software development kit to enhance networking capabilities. By emphasizing scalability, low latency, and advanced telemetry, Innovium aims to deliver high-performance, feature-rich networking solutions that meet the evolving demands of its clients.

Gradyent

Seed Round in 2020
Gradyent is an AI cloud platform based in Utrecht, The Netherlands, founded in 2019. It specializes in optimizing heating systems for district heating companies, effectively reducing CO2 emissions and improving energy efficiency. Utilizing Digital Twin technology, Gradyent creates a digital replica of physical heating systems by integrating geographical, weather, and sensor data with physical models and artificial intelligence. This innovative approach allows real-time optimization of heating systems, enabling users to simulate future scenarios and make informed decisions. As a result, clients experience significant savings, with an average reduction of 20% in heat loss, 10% in CO2 emissions, and 5-10% in fuel costs. Gradyent's platform also offers dynamic forecasting and the capability to monitor network status, making it accessible for clients to securely manage their networks from anywhere at any time.

ViroVet

Series B in 2020
ViroVet is an innovative company focused on developing advanced technologies to combat viral diseases in livestock. Its product pipeline includes antiviral drugs targeting respiratory disease complexes and novel vaccines for swine viral infections. Given the substantial economic impact of viral diseases, which cost the livestock industry billions annually, ViroVet aims to provide effective solutions that can be used independently or alongside existing vaccines and biosecurity measures. The company addresses the growing demand for animal protein amid increasing global population and livestock density, as well as climate change challenges that heighten the risk of viral outbreaks. ViroVet has garnered support from key opinion leaders in livestock medicine, who recognize the potential of its products to transform the industry, notably by reducing antibiotic usage and enhancing overall animal health and productivity.

VOID Technologies

Venture Round in 2020
VOID Technologies Limited is a materials science company that specializes in the manufacture and supply of VO+ additive masterbatches, primarily for film manufacturers. Established in 2014 and headquartered in London, UK, with a manufacturing facility in Neenah, Wisconsin, the company focuses on incorporating plastic reduction techniques into various applications. Its innovative technology engineers a nano-voided structure within commodity and biopolymers, resulting in lighter and more sustainable products. This advancement allows packaging manufacturers and consumer goods companies to create films suitable for a wide range of uses, including packaging, industrial, agricultural, and medical applications. VOID Technologies operates as a subsidiary of Kimberly-Clark Corporation, emphasizing its commitment to sustainability and innovation in the materials sector.

Prolupin

Venture Round in 2020
Prolupin GmbH is a German company founded in 2010, specializing in the development and production of plant-based food ingredients derived from lupine seeds. Based in Grimmen, Prolupin offers a range of products tailored for various sectors of the food industry, including bakery, meat, pasta, and health foods. The company's portfolio includes lupine ingredients, ice cream products, and protein isolates, emphasizing vegan and gluten-free options. As a spin-off from the Fraunhofer Institute for Process Engineering and Packaging, Prolupin benefits from advanced expertise in lupine fractionation and food technology, reinforced by several patents held by the institute. This positions the company strongly within the growing market for vegetable proteins, catering to the increasing demand for cholesterol and lactose-free alternatives.

DMC Biotechnologies

Series A in 2019
DMC Biotechnologies, Inc. is a biotechnology company based in Boulder, Colorado, that specializes in the development of bio-based products through microbial fermentation technology. Founded in 2014, the company focuses on engineering microbial hosts to produce a range of specialty chemicals, flavors, fragrances, nutraceuticals, natural products, and pharmaceuticals. DMC Biotechnologies employs its proprietary Dynamic Metabolic Control technology to enhance production efficiency, thereby reducing costs and accelerating the timeline from discovery to commercial performance. The company's innovative approach supports sustainability by utilizing lower energy and resource inputs in the manufacturing process.

iSTAR Medical

Series C in 2019
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established itself in the field with its flagship product, the STARflo glaucoma implant. This non-degradable, precision-pore device functions as a micro-porous drainage system that reduces intraocular pressure by enhancing the eye’s natural uveoscleral outflow. iSTAR Medical's offerings also include STARflo PLUS and STARflo MINI surgical therapies, which incorporate anti-fibrotic and anti-inflammatory properties to improve patient outcomes. The company operates from its eco-friendly R&D and manufacturing facility in CREALYS Scientific Park near Namur, Belgium, and distributes its products through various international partners across Europe and Asia. iSTAR Medical is committed to providing advanced and effective treatment alternatives for glaucoma patients, with its devices designed to limit inflammation and fibrosis while promoting bio-integration with surrounding tissues.

Arkite NV

Venture Round in 2019
Arkite NV is a Belgian company, founded in 2015 and based in Genk, that focuses on manufacturing automation products designed to enhance manufacturing operations. Its primary product, the Human Interface Mate (HIM), assists operators by providing immediate warnings when incorrect operations occur and guiding them towards standardized work processes. The company prides itself on a dedicated team with expertise in industrial engineering, lean thinking, and process innovation. In addition to its technological offerings, Arkite NV provides professional services, including process innovation consultancy, integration services, and training to support the implementation of its products. The company also aids clients in conducting time studies for technology innovation and improving quality systems, ultimately aiming to reduce waste and streamline operations.

icometrix

Series A in 2019
icometrix is a technology company that specializes in the analysis of brain MRI images using artificial intelligence. Founded in 2011 as a spin-off from the universities and university hospitals of Leuven and Antwerp, icometrix has established itself as a leader in providing standardized measurements for patients with neurological disorders. The company’s flagship product, MSmetrix, is designed to detect brain lesions and assess various brain metrics, including lesion volume and atrophy, with regulatory approvals in the EU, Canada, Brazil, and Australia. Based in Leuven, with an office in Boston, icometrix employs over 25 professionals and is internationally active. The company also serves as an image analysis expert in clinical trials and research studies, where it processes large volumes of brain imaging data to derive insights into conditions such as traumatic brain injury, epilepsy, Alzheimer's disease, and stroke. icometrix is certified in quality management and information security, underscoring its commitment to maintaining high standards in medical devices and data handling.

Confo Therapeutics

Series A in 2019
Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company specializes in developing internal drug discovery programs focused on G-protein coupled receptors (GPCRs) to address unmet medical needs. Utilizing its proprietary CONFO technology, Confo Therapeutics stabilizes the inherently unstable functional conformations of GPCRs, providing a robust framework for drug discovery. This innovative approach reveals previously inaccessible structural features of these receptors, facilitating the discovery of novel agonists and enhancing therapeutic interventions. By concentrating on stabilizing GPCRs, Confo Therapeutics aims to significantly advance the development of new treatments in the medical field.

Miaa Guard

Venture Round in 2019
Miaa Guard CVBA, based in Leuven, Belgium, develops a cloud-based platform that provides access control solutions for digital businesses. The platform utilizes microservice APIs to manage access rights and policies tailored to both consumers and professionals within an enterprise context. It enables organizations to govern security and access, integrate data architecture, and customize configurations. Founded in 2009 and originally known as VintiQ, the company rebranded to Miaa Guard CVBA in 2014. Its services facilitate the monetization of digital assets while ensuring proper authorization among users.

Black Bear Carbon

Venture Round in 2018
Black Bear Carbon BV specializes in the conversion of waste tires into carbon black and green energy, operating from its base in Nederweert, the Netherlands, since its founding in 2010. The company utilizes a circular economy model, transforming end-of-life tires into sustainable products that serve various industries. Its carbon black, derived from controlled pyrolysis and partial combustion of hydrocarbons, is utilized in applications such as tires, technical rubber products, plastics, paints, and inks. In addition to producing carbon black, Black Bear Carbon generates electricity from its operations, which powers its tire shredding processes and supplies energy to local industries and grids. Through these efforts, the company provides businesses with recyclable carbon compounds, contributing to reduced reliance on oil and lower carbon dioxide emissions.

c-LEcta

Venture Round in 2018
c-LEcta GmbH is a biotechnology company established in 2004 and headquartered in Leipzig, Germany. The company specializes in enzyme engineering and bioprocess development, primarily serving regulated markets such as food and pharmaceuticals. c-LEcta focuses on the development, manufacture, and commercialization of application-oriented enzyme variants, which are offered either as proprietary products or through collaborative development with industry partners. Among its key products are DENARASE, a genetically engineered endonuclease designed for the quantitative removal of nucleic acids and viscosity reduction, and CalB Immo Plus, a hydrophobic immobilized CalB preparation. The company aims to provide customized enzymes and microbial strains for various industrial applications, supporting clients in making new discoveries and enhancing market penetration through cost-efficient and sustainable production processes.

Nexstim

Post in 2018
Nexstim Plc is a medical technology company based in Helsinki, Finland, specializing in non-invasive brain stimulation technologies. Founded in 2000, the company has developed the SmartFocus technology, which utilizes navigated transcranial magnetic stimulation (TMS) with 3D navigation for precise targeting of brain areas. Nexstim's product offerings include the NBT system, designed for treating major depressive disorder and chronic neuropathic pain, and the NBS system, used for pre-surgical mapping of the speech and motor cortices. The NBS systems are primarily sold to universities and teaching hospitals. Nexstim operates in various markets, including Finland, Europe, and North America, with a significant portion of its revenue generated in North America. The company's commitment lies in addressing significant unmet clinical needs and improving the quality of life for patients.

LindaCare

Series B in 2018
LindaCare LTD. is a Belgium-based company specializing in patient tele-monitoring solutions for chronic disease management. The company has developed a comprehensive dashboard that integrates tele-monitoring data from various cardiac implantable device vendors and electronic patient records. This vendor-independent software platform enhances workflow automation, provides customized alerts, and minimizes medical errors, thereby improving the efficiency of patient care. By offering healthcare professionals and hospitals a unified system, LindaCare aims to reduce the cost of care delivery while enhancing the quality and safety of patient management. The software enables both healthcare professionals and family members to effectively track and monitor patient activities remotely.

DMC Biotechnologies

Seed Round in 2018
DMC Biotechnologies, Inc. is a biotechnology company based in Boulder, Colorado, that specializes in the development of bio-based products through microbial fermentation technology. Founded in 2014, the company focuses on engineering microbial hosts to produce a range of specialty chemicals, flavors, fragrances, nutraceuticals, natural products, and pharmaceuticals. DMC Biotechnologies employs its proprietary Dynamic Metabolic Control technology to enhance production efficiency, thereby reducing costs and accelerating the timeline from discovery to commercial performance. The company's innovative approach supports sustainability by utilizing lower energy and resource inputs in the manufacturing process.

Ngdata

Series C in 2017
NGDATA, headquartered in Ghent, Belgium, specializes in consumer intelligence management solutions. The company offers a customer data platform that integrates big data management and machine learning technologies, providing real-time insights and enabling personalized customer experiences. NGDATA serves various industries, including finance, retail, and media, with offices in Belgium, France, Singapore, and the United States.

Arkite NV

Venture Round in 2017
Arkite NV is a Belgian company, founded in 2015 and based in Genk, that focuses on manufacturing automation products designed to enhance manufacturing operations. Its primary product, the Human Interface Mate (HIM), assists operators by providing immediate warnings when incorrect operations occur and guiding them towards standardized work processes. The company prides itself on a dedicated team with expertise in industrial engineering, lean thinking, and process innovation. In addition to its technological offerings, Arkite NV provides professional services, including process innovation consultancy, integration services, and training to support the implementation of its products. The company also aids clients in conducting time studies for technology innovation and improving quality systems, ultimately aiming to reduce waste and streamline operations.

Sensolus

Seed Round in 2017
Sensolus NV specializes in the design and development of GPS trackers for non-powered assets, offering comprehensive solutions for tracking and monitoring these items through advanced wireless technology. Founded in 2013 and based in Ghent, Belgium, the company combines expertise in low-power networks and wireless sensor design to deliver innovative tracking systems, including their personal product line, STICKNTRACK. Sensolus provides a cloud-based platform that enables users to access real-time information about their assets, making the management of valuable equipment in industries such as manufacturing, waste management, cargo transport, logistics, and automotive efficient and straightforward. Their offerings focus on affordable, easy-to-install, and maintenance-free tracking solutions, ensuring seamless asset management for users.

ViroVet

Series A in 2017
ViroVet is an innovative company focused on developing advanced technologies to combat viral diseases in livestock. Its product pipeline includes antiviral drugs targeting respiratory disease complexes and novel vaccines for swine viral infections. Given the substantial economic impact of viral diseases, which cost the livestock industry billions annually, ViroVet aims to provide effective solutions that can be used independently or alongside existing vaccines and biosecurity measures. The company addresses the growing demand for animal protein amid increasing global population and livestock density, as well as climate change challenges that heighten the risk of viral outbreaks. ViroVet has garnered support from key opinion leaders in livestock medicine, who recognize the potential of its products to transform the industry, notably by reducing antibiotic usage and enhancing overall animal health and productivity.

FEops

Series B in 2017
FEops is a pioneering company specializing in physics-based simulations for minimally invasive cardiovascular devices and procedures. It develops advanced cardiac imaging technology that enhances personalized treatment for patients with structural heart disease. By providing artificial intelligence-enabled anatomical analyses, FEops generates data-driven insights that facilitate improvements in transcatheter valve procedures. The company collaborates with medical device developers and healthcare professionals, offering valuable simulations that accelerate research and development processes while ensuring device safety. Physicians benefit from these patient-specific insights, which enhance their efficiency and ultimately lead to improved clinical outcomes and patient safety.

Ngdata

Series B in 2017
NGDATA, headquartered in Ghent, Belgium, specializes in consumer intelligence management solutions. The company offers a customer data platform that integrates big data management and machine learning technologies, providing real-time insights and enabling personalized customer experiences. NGDATA serves various industries, including finance, retail, and media, with offices in Belgium, France, Singapore, and the United States.

Indigo Diabetes

Series A in 2016
Indigo Diabetes, established in 2016 and headquartered in Ghent, Belgium, specializes in developing innovative, non-invasive glucose monitoring solutions. The company's flagship product is an invisible, photonics-based sensor that is inserted under the skin, continuously measuring blood sugar levels, thereby eliminating the need for traditional finger pricks. Indigo Diabetes aims to enhance the lives of people with diabetes by providing accurate glucose monitoring with an improved user experience.

Noona Healthcare

Seed Round in 2016
Noona Healthcare Oy, established in 2014 and headquartered in Helsinki, Finland, specializes in developing a Web-based mobile service called Noona. This platform enables breast cancer patients to directly report treatment-related symptoms to their clinics via mobile phones, tablets, and computers, fostering real-time, holistic patient monitoring. Additionally, Noona's platform facilitates scientific research by generating digital data that combines patient diagnosis, treatment, and genetic information, aiding in the development of new cancer therapies. As of 2018, Noona Healthcare operates as a subsidiary of Varian Medical Systems, Inc.

FRX Innovations

Series D in 2016
FRX Innovations is an industrial manufacturer based in Chelmsford, MA, specializing in environmentally sustainable flame retardant solutions within the plastics and additives market. The company produces Nofia polyphosphonates, a family of non-halogen, transparent, and high melt flowing fire-resistant plastics. FRX Innovations focuses on delivering high value-added solutions to various sectors, including textiles, electronics, automotive, electric vehicles, and medical devices. Its products are developed using sustainable green chemistry principles, featuring a solvent-free production process that generates no waste byproducts and maximizes atom efficiency. Through its innovative offerings, FRX Innovations aims to address the growing demand for safer and more sustainable materials in multiple industries.

Diagenode

Venture Round in 2016
Diagenode is an international life sciences company established in 2003 in Liège, Belgium, with a presence in Sparta, New Jersey, and a sales office in the United Kingdom. The company specializes in developing and commercializing advanced instruments and reagent systems for life science research and molecular diagnostics. Diagenode offers a technology platform that includes Bioruptor shearing and IP-Star automation instruments, along with reagent kits and quality antibodies. These products are designed to enhance workflows in epigenetics research, biological sample preparation, and diagnostic assays, serving a diverse clientele that includes prominent epigenetics researchers, academic institutions, genome centers, core laboratories, and pharmaceutical and biotechnology companies.

iSTAR Medical

Series B in 2016
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established itself in the field with its flagship product, the STARflo glaucoma implant. This non-degradable, precision-pore device functions as a micro-porous drainage system that reduces intraocular pressure by enhancing the eye’s natural uveoscleral outflow. iSTAR Medical's offerings also include STARflo PLUS and STARflo MINI surgical therapies, which incorporate anti-fibrotic and anti-inflammatory properties to improve patient outcomes. The company operates from its eco-friendly R&D and manufacturing facility in CREALYS Scientific Park near Namur, Belgium, and distributes its products through various international partners across Europe and Asia. iSTAR Medical is committed to providing advanced and effective treatment alternatives for glaucoma patients, with its devices designed to limit inflammation and fibrosis while promoting bio-integration with surrounding tissues.

BlueBee

Series A in 2016
Bluebee is a prominent provider of high-performance genomics solutions, specializing in a cloud-based platform designed for the efficient processing of large volumes of genomic data. This platform addresses the challenges faced by research and clinical laboratories in the rapidly evolving landscape of genetic analysis, particularly with the advent of next-generation DNA sequencing technology. By offering a solution that enhances data processing speed, deep analytics, and flexibility, Bluebee enables healthcare institutions to implement whole genome-based diagnostics more effectively. The company's innovative approach allows for cost-effective genetic screening, supporting the development of new diagnostics and therapies in healthcare while maintaining clinical-grade security and user convenience.

LindaCare

Series A in 2015
LindaCare LTD. is a Belgium-based company specializing in patient tele-monitoring solutions for chronic disease management. The company has developed a comprehensive dashboard that integrates tele-monitoring data from various cardiac implantable device vendors and electronic patient records. This vendor-independent software platform enhances workflow automation, provides customized alerts, and minimizes medical errors, thereby improving the efficiency of patient care. By offering healthcare professionals and hospitals a unified system, LindaCare aims to reduce the cost of care delivery while enhancing the quality and safety of patient management. The software enables both healthcare professionals and family members to effectively track and monitor patient activities remotely.

Ngdata

Series B in 2015
NGDATA, headquartered in Ghent, Belgium, specializes in consumer intelligence management solutions. The company offers a customer data platform that integrates big data management and machine learning technologies, providing real-time insights and enabling personalized customer experiences. NGDATA serves various industries, including finance, retail, and media, with offices in Belgium, France, Singapore, and the United States.

Sequana Medical

Series C in 2015
Sequana Medical is a Swiss medical device company based in Zurich that specializes in developing and commercializing implantable pump systems to manage fluid balance within the body. The company's flagship product, the Alfapump System, is designed to automatically and continually remove ascites, which is excess fluid that accumulates in the abdominal cavity due to advanced liver disease, certain cancers, or congestive heart failure. This system moves the excess fluid to the bladder for natural elimination through urination. Sequana Medical's technology also has potential applications in managing pleural effusions in lung disease patients and fluid overload in those with end-stage renal disease and congestive heart failure. The company was founded in 2006 and has additional offices in Munich, Germany.

Ogeda

Series B in 2015
Ogeda SA is a clinical-stage drug discovery company based in Gosselies, Belgium, that specializes in the invention and development of small molecule drugs targeting G-Protein Coupled Receptors (GPCRs). Founded in 1994 and formerly known as Euroscreen, the company focuses on developing innovative therapies for women's health disorders, with its lead product, fezolinetant, currently in Phase II clinical development. In addition to fezolinetant, Ogeda is advancing other small molecules aimed at treating various endocrine, central nervous system, and inflammatory conditions. The company maintains facilities in Brussels and Paris, and operates as a subsidiary of Astellas Pharma Inc. Through its research, Ogeda seeks to provide effective treatment options for hormone-dependent pathologies and other related health issues.

NovoPolymers

Venture Round in 2015
NovoPolymers NV is a company focused on creating sustainable solutions tailored for the photovoltaic market. It specializes in the development and production of front and back encapsulants that protect solar cells. These encapsulants are designed to enhance the power output of both crystalline silicon and thin-film solar modules, thereby adding value across the photovoltaic supply chain. Through its innovative products, NovoPolymers aims to contribute to the advancement of renewable energy technologies.

FEops

Series A in 2015
FEops is a pioneering company specializing in physics-based simulations for minimally invasive cardiovascular devices and procedures. It develops advanced cardiac imaging technology that enhances personalized treatment for patients with structural heart disease. By providing artificial intelligence-enabled anatomical analyses, FEops generates data-driven insights that facilitate improvements in transcatheter valve procedures. The company collaborates with medical device developers and healthcare professionals, offering valuable simulations that accelerate research and development processes while ensuring device safety. Physicians benefit from these patient-specific insights, which enhance their efficiency and ultimately lead to improved clinical outcomes and patient safety.

Green Biologics

Series C in 2015
Green Biologics Limited is an industrial biotechnology company based in Abingdon, United Kingdom, specializing in renewable specialty chemicals. The company produces n-butanol, acetone, and C4 derivatives, along with GreenFlame charcoal lighting fluids. These products serve various applications across industries, including paints, coatings, adhesives, personal care, cosmetics, fragrances, food ingredients, health, and household cleaners. Green Biologics aims to become a leading supplier of advanced fermentation technologies that convert biomass into renewable fuels and chemicals. Founded in 2002, the company also maintains pilot, demo, and lab facilities in the United States, along with satellite offices in China, Brazil, and India.

SpaceX

Series G in 2015
SpaceX, officially known as Space Exploration Technologies, is a space transportation company founded in 2002 by Elon Musk and headquartered in Hawthorne, California. The company specializes in the design, manufacture, and launch of advanced rockets and spacecraft, including notable vehicles such as Falcon Heavy, Dragon, and Starship. SpaceX develops a range of technologies including crew and cargo capsules, rocket engines, and avionics, alongside guidance and control software. A key focus of SpaceX is the creation of partially reusable launch vehicles, such as Falcon 1 and Falcon 9, which aim to reduce the costs associated with space travel. By enabling the transport of cargo, humans, and payloads into space, SpaceX seeks to advance the capabilities and affordability of space exploration and travel.

Avantium

Series G in 2014
Avantium is a Dutch technology company specializing in advanced high-throughput research and development for energy, chemicals, and pharmaceutical industries. Headquartered in Amsterdam with state-of-the-art laboratories, Avantium's proprietary technology accelerates product and process innovation while reducing costs. With over 70 global clients, including industry leaders, Avantium has proven its technology's validity and commercial viability. The company focuses on developing new biofuels, bio-based chemicals, and novel crystal forms of marketed drugs under patent. Its team comprises highly educated professionals in catalysis, crystallography, organic chemistry, engineering, statistics, cheminformatics, and software development, collaborating closely with partner R&D organizations to drive innovation.

Sequana Medical

Series C in 2014
Sequana Medical is a Swiss medical device company based in Zurich that specializes in developing and commercializing implantable pump systems to manage fluid balance within the body. The company's flagship product, the Alfapump System, is designed to automatically and continually remove ascites, which is excess fluid that accumulates in the abdominal cavity due to advanced liver disease, certain cancers, or congestive heart failure. This system moves the excess fluid to the bladder for natural elimination through urination. Sequana Medical's technology also has potential applications in managing pleural effusions in lung disease patients and fluid overload in those with end-stage renal disease and congestive heart failure. The company was founded in 2006 and has additional offices in Munich, Germany.

FRX Innovations

Series C in 2014
FRX Innovations is an industrial manufacturer based in Chelmsford, MA, specializing in environmentally sustainable flame retardant solutions within the plastics and additives market. The company produces Nofia polyphosphonates, a family of non-halogen, transparent, and high melt flowing fire-resistant plastics. FRX Innovations focuses on delivering high value-added solutions to various sectors, including textiles, electronics, automotive, electric vehicles, and medical devices. Its products are developed using sustainable green chemistry principles, featuring a solvent-free production process that generates no waste byproducts and maximizes atom efficiency. Through its innovative offerings, FRX Innovations aims to address the growing demand for safer and more sustainable materials in multiple industries.

Arcus Financial Intelligence

Seed Round in 2014
Arcus Financial Intelligence, Inc. is a New York-based company that develops and operates a comprehensive application program interface (API) platform tailored for banks and financial institutions. Founded in 2012 and formerly known as Regalii Inc., Arcus specializes in managing consumer bills and financial data. Its platform enables real-time bill management and payment services, providing users with a detailed overview of their financial obligations, including the number of bills, amounts owed, and due dates. Additionally, Arcus offers a multi-rail payment platform that facilitates accessible payment solutions for businesses, supporting various payment methods such as account-to-account transfers and cash transactions.

Green Biologics

Series B in 2013
Green Biologics Limited is an industrial biotechnology company based in Abingdon, United Kingdom, specializing in renewable specialty chemicals. The company produces n-butanol, acetone, and C4 derivatives, along with GreenFlame charcoal lighting fluids. These products serve various applications across industries, including paints, coatings, adhesives, personal care, cosmetics, fragrances, food ingredients, health, and household cleaners. Green Biologics aims to become a leading supplier of advanced fermentation technologies that convert biomass into renewable fuels and chemicals. Founded in 2002, the company also maintains pilot, demo, and lab facilities in the United States, along with satellite offices in China, Brazil, and India.

iSTAR Medical

Series A in 2013
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established itself in the field with its flagship product, the STARflo glaucoma implant. This non-degradable, precision-pore device functions as a micro-porous drainage system that reduces intraocular pressure by enhancing the eye’s natural uveoscleral outflow. iSTAR Medical's offerings also include STARflo PLUS and STARflo MINI surgical therapies, which incorporate anti-fibrotic and anti-inflammatory properties to improve patient outcomes. The company operates from its eco-friendly R&D and manufacturing facility in CREALYS Scientific Park near Namur, Belgium, and distributes its products through various international partners across Europe and Asia. iSTAR Medical is committed to providing advanced and effective treatment alternatives for glaucoma patients, with its devices designed to limit inflammation and fibrosis while promoting bio-integration with surrounding tissues.

Trod Medical

Series B in 2013
Trod Medical S.A. is a medical device manufacturer founded in 2006, with its headquarters located in Leuven, Belgium, and a presence in the Tampa Bay area, USA. The company specializes in innovative ablation technologies, particularly in the development of radiofrequency (RF) ablation devices. Trod Medical's flagship product, the EncageTM, is a percutaneous RF device designed to ablate soft tissues with exceptional precision, significantly reducing collateral damage compared to conventional treatments. This advancement is particularly relevant in the treatment of prostate cancer, a prevalent condition that affects around 240,000 new patients annually in the United States. The company aims to address the limitations of existing therapies, which often lead to serious side effects such as erectile dysfunction and urinary incontinence. Through its focus on focal ablation techniques, Trod Medical is committed to improving patient outcomes and enhancing surgical efficacy.

Ngdata

Series A in 2013
NGDATA, headquartered in Ghent, Belgium, specializes in consumer intelligence management solutions. The company offers a customer data platform that integrates big data management and machine learning technologies, providing real-time insights and enabling personalized customer experiences. NGDATA serves various industries, including finance, retail, and media, with offices in Belgium, France, Singapore, and the United States.

Green Biologics

Venture Round in 2013
Green Biologics Limited is an industrial biotechnology company based in Abingdon, United Kingdom, specializing in renewable specialty chemicals. The company produces n-butanol, acetone, and C4 derivatives, along with GreenFlame charcoal lighting fluids. These products serve various applications across industries, including paints, coatings, adhesives, personal care, cosmetics, fragrances, food ingredients, health, and household cleaners. Green Biologics aims to become a leading supplier of advanced fermentation technologies that convert biomass into renewable fuels and chemicals. Founded in 2002, the company also maintains pilot, demo, and lab facilities in the United States, along with satellite offices in China, Brazil, and India.

Mainstay Medical

Series B in 2012
Mainstay Medical is a global medical device company based in Dublin, Ireland, with additional operations in the United States and Australia. The company specializes in developing innovative therapies for individuals suffering from chronic low back pain, a condition that affects a significant underserved population. Mainstay Medical has created an FDA-approved restorative treatment designed to enhance muscle control and improve functionality in the lumbar spine. This therapy aims to help patients regain mobility and enhance their overall quality of life. By collaborating with scientists and clinical experts, Mainstay Medical is committed to advancing solutions for those affected by debilitating back pain.

Metallkraft AS

Acquisition in 2012
Metallkraft AS processes and recovers silicon carbide, polyethylene glycol, and SiSiCar from spent cutting fluid employed in the production of silicon wafers by the solar and integrated circuitry industries. Its products include slurry recovery, SIC, and glycol; and SiSiCar, a silicon carbide.

Green Biologics

Venture Round in 2012
Green Biologics Limited is an industrial biotechnology company based in Abingdon, United Kingdom, specializing in renewable specialty chemicals. The company produces n-butanol, acetone, and C4 derivatives, along with GreenFlame charcoal lighting fluids. These products serve various applications across industries, including paints, coatings, adhesives, personal care, cosmetics, fragrances, food ingredients, health, and household cleaners. Green Biologics aims to become a leading supplier of advanced fermentation technologies that convert biomass into renewable fuels and chemicals. Founded in 2002, the company also maintains pilot, demo, and lab facilities in the United States, along with satellite offices in China, Brazil, and India.

Trinean

Venture Round in 2012
Trinean is a Belgium-based technology provider specializing in micro-volume molecular spectroscopy. Founded in 2006 as a spin-out from Ghent University and Imec Leuven, the company develops UV/VIS spectrometers for biomolecule quantification. Their flagship products, the DropSense™16 and DropSense™96, analyze up to 16 and 96 samples respectively, utilizing microfluidic chips for standardized sample analysis through DropPlates™ and Slides. Trinean's platform is enhanced with a software toolbox designed to improve data interpretation and lab automation, catering to the needs of biologics researchers.

NovoPolymers

Venture Round in 2012
NovoPolymers NV is a company focused on creating sustainable solutions tailored for the photovoltaic market. It specializes in the development and production of front and back encapsulants that protect solar cells. These encapsulants are designed to enhance the power output of both crystalline silicon and thin-film solar modules, thereby adding value across the photovoltaic supply chain. Through its innovative products, NovoPolymers aims to contribute to the advancement of renewable energy technologies.

Liquidity Nanotech Corporation

Series A in 2011
Liquidity manufactures breakthrough water purification cartridges, based on revolutionary membrane nanoscience, to solve the world's potable water needs. Pour any non-salt water through their cartridge and drink it safely. It's that simple. No chemicals, no power nor pressure. Their product will save millions of lives currently lost to preventable waterborne diseases.

EpiGan

Venture Round in 2011
EpiGaN is a Leuven, Belgium-based company specializing in the development of Gallium Nitride (GaN) on silicon wafers. The company focuses on providing III-nitride epitaxial materials that are designed for various commercial applications. EpiGaN's GaN materials offer higher power efficiency, which helps to reduce power losses in a range of uses, including AC drives, uninterruptible power supplies (UPS), and hybrid and electric vehicles. Through its innovative technology, EpiGaN aims to enhance the performance and efficiency of electronic systems across multiple industries.

FRX Innovations

Series B in 2011
FRX Innovations is an industrial manufacturer based in Chelmsford, MA, specializing in environmentally sustainable flame retardant solutions within the plastics and additives market. The company produces Nofia polyphosphonates, a family of non-halogen, transparent, and high melt flowing fire-resistant plastics. FRX Innovations focuses on delivering high value-added solutions to various sectors, including textiles, electronics, automotive, electric vehicles, and medical devices. Its products are developed using sustainable green chemistry principles, featuring a solvent-free production process that generates no waste byproducts and maximizes atom efficiency. Through its innovative offerings, FRX Innovations aims to address the growing demand for safer and more sustainable materials in multiple industries.

Nexstim

Venture Round in 2011
Nexstim Plc is a medical technology company based in Helsinki, Finland, specializing in non-invasive brain stimulation technologies. Founded in 2000, the company has developed the SmartFocus technology, which utilizes navigated transcranial magnetic stimulation (TMS) with 3D navigation for precise targeting of brain areas. Nexstim's product offerings include the NBT system, designed for treating major depressive disorder and chronic neuropathic pain, and the NBS system, used for pre-surgical mapping of the speech and motor cortices. The NBS systems are primarily sold to universities and teaching hospitals. Nexstim operates in various markets, including Finland, Europe, and North America, with a significant portion of its revenue generated in North America. The company's commitment lies in addressing significant unmet clinical needs and improving the quality of life for patients.

Sequana Medical

Series B in 2011
Sequana Medical is a Swiss medical device company based in Zurich that specializes in developing and commercializing implantable pump systems to manage fluid balance within the body. The company's flagship product, the Alfapump System, is designed to automatically and continually remove ascites, which is excess fluid that accumulates in the abdominal cavity due to advanced liver disease, certain cancers, or congestive heart failure. This system moves the excess fluid to the bladder for natural elimination through urination. Sequana Medical's technology also has potential applications in managing pleural effusions in lung disease patients and fluid overload in those with end-stage renal disease and congestive heart failure. The company was founded in 2006 and has additional offices in Munich, Germany.

NovoPolymers

Series B in 2011
NovoPolymers NV is a company focused on creating sustainable solutions tailored for the photovoltaic market. It specializes in the development and production of front and back encapsulants that protect solar cells. These encapsulants are designed to enhance the power output of both crystalline silicon and thin-film solar modules, thereby adding value across the photovoltaic supply chain. Through its innovative products, NovoPolymers aims to contribute to the advancement of renewable energy technologies.

Ensartech

Venture Round in 2011
Ensartech is engages in mastering high temperature processes to process highly polluted waste and residual streams of various industries and convert them into various types of energy.

Ducatt

Venture Round in 2010
Ducatt NV is a clean-tech start-up located in Belgium that specializes in the manufacturing of solar glasses. The company's products are designed to enhance the efficiency of solar systems by utilizing ultra-clear patterned glasses available in various thicknesses. Ducatt aims to provide clients with an affordable solution to improve solar energy usage, contributing to the advancement of clean energy technologies.

Green Biologics

Series B in 2010
Green Biologics Limited is an industrial biotechnology company based in Abingdon, United Kingdom, specializing in renewable specialty chemicals. The company produces n-butanol, acetone, and C4 derivatives, along with GreenFlame charcoal lighting fluids. These products serve various applications across industries, including paints, coatings, adhesives, personal care, cosmetics, fragrances, food ingredients, health, and household cleaners. Green Biologics aims to become a leading supplier of advanced fermentation technologies that convert biomass into renewable fuels and chemicals. Founded in 2002, the company also maintains pilot, demo, and lab facilities in the United States, along with satellite offices in China, Brazil, and India.

Anteryon International

Venture Round in 2010
Anteryon International, established in 2006, specializes in designing, manufacturing, and distributing high-precision optical components. Its product portfolio includes a wide range of lenses, laser modules, optical mirrors, filters, and custom opto-mechatronic assemblies. Serving diverse sectors such as medical, telecom, defense, and semiconductor industries, the company leverages its patented replication and opto-mechanical assembly technology, along with deep domain expertise, to deliver standard and customer-specific optical solutions. Headquartered in Eindhoven, the Netherlands, Anteryon International operates as a subsidiary of China Wafer Level CSP Co., Ltd.

FRX Innovations

Series A in 2009
FRX Innovations is an industrial manufacturer based in Chelmsford, MA, specializing in environmentally sustainable flame retardant solutions within the plastics and additives market. The company produces Nofia polyphosphonates, a family of non-halogen, transparent, and high melt flowing fire-resistant plastics. FRX Innovations focuses on delivering high value-added solutions to various sectors, including textiles, electronics, automotive, electric vehicles, and medical devices. Its products are developed using sustainable green chemistry principles, featuring a solvent-free production process that generates no waste byproducts and maximizes atom efficiency. Through its innovative offerings, FRX Innovations aims to address the growing demand for safer and more sustainable materials in multiple industries.

NovoPolymers

Series A in 2009
NovoPolymers NV is a company focused on creating sustainable solutions tailored for the photovoltaic market. It specializes in the development and production of front and back encapsulants that protect solar cells. These encapsulants are designed to enhance the power output of both crystalline silicon and thin-film solar modules, thereby adding value across the photovoltaic supply chain. Through its innovative products, NovoPolymers aims to contribute to the advancement of renewable energy technologies.

Neosens

Series B in 2009
Neosens SA is a company focused on designing and developing advanced sensor solutions and technologies for monitoring and controlling the quality of water and industrial liquids. Established in 2001 and headquartered in Labege, France, Neosens specializes in microelectronic sensors that measure dissolved oxygen levels and monitor fouling in various liquid environments. Its products find applications in diverse sectors, including cooling systems, heat exchangers, potable and ultra-pure water, industrial boilers, and industries such as food and beverage, pharmaceuticals, pulp and paper, oil, gas, and petrochemicals. Neosens aims to enhance environmental monitoring and process efficiency through its innovative sensor technologies.

Metallkraft AS

Series A in 2008
Metallkraft AS processes and recovers silicon carbide, polyethylene glycol, and SiSiCar from spent cutting fluid employed in the production of silicon wafers by the solar and integrated circuitry industries. Its products include slurry recovery, SIC, and glycol; and SiSiCar, a silicon carbide.

Avantium

Venture Round in 2008
Avantium is a Dutch technology company specializing in advanced high-throughput research and development for energy, chemicals, and pharmaceutical industries. Headquartered in Amsterdam with state-of-the-art laboratories, Avantium's proprietary technology accelerates product and process innovation while reducing costs. With over 70 global clients, including industry leaders, Avantium has proven its technology's validity and commercial viability. The company focuses on developing new biofuels, bio-based chemicals, and novel crystal forms of marketed drugs under patent. Its team comprises highly educated professionals in catalysis, crystallography, organic chemistry, engineering, statistics, cheminformatics, and software development, collaborating closely with partner R&D organizations to drive innovation.

Fluxome

Series B in 2008
Fluxome is a global supplier of natural ingredients aimed at enhancing human health and wellness. The company specializes in producing nutraceutical ingredients, notably pure resveratrol, derived from renewable sources through innovative technology. Fluxome's commitment to developing safe and natural health products distinguishes it in the market, as it seeks to provide effective solutions that can positively impact its customers' well-being.

Ensartech

Venture Round in 2008
Ensartech is engages in mastering high temperature processes to process highly polluted waste and residual streams of various industries and convert them into various types of energy.

CoreOptics

Venture Round in 2008
CoreOptics is a prominent manufacturer of advanced subsystems designed for high-speed optical networking applications in the telecommunications and information technology sectors. The company specializes in 10G and 40G Distortion Tolerant Transponder Modules and integrated circuit solutions, catering to Metro, Regional, and Long Haul optical and data networking markets. CoreOptics advocates for open systems in optical communications networks, enabling efficient data transmission regardless of data rates or fiber types. Their innovative maximum likelihood sequence estimation (MLSE)-based equalization technology is the only field-proven solution available, empowering Tier 1 systems vendors and carriers to enhance their high-performance networks using existing fiber infrastructure. By eliminating the need for Optical Compensators and associated Second Stage Amplifiers, CoreOptics' products can significantly reduce initial deployment costs for customers, making them a valuable partner in the evolution of optical networking.

iNEWiT

Venture Round in 2008
iNEWiT is an engineering company based in Mechelen, Belgium, founded in 2005. It specializes in identifying, designing, and creating applications and devices tailored for the mobile market. The company develops mobile video communication applications utilizing its patent-pending technology to transmit data, video, and sound across various wireless and wired platforms. iNEWiT also offers wireless communication technologies that encompass GPRS/EDGE, 3G, HSDPA/HSUPA, WiFi, WiMAX, and satellite networks. Additionally, it provides plug-and-play products aimed at the business-to-consumer markets.

Neosens

Venture Round in 2008
Neosens SA is a company focused on designing and developing advanced sensor solutions and technologies for monitoring and controlling the quality of water and industrial liquids. Established in 2001 and headquartered in Labege, France, Neosens specializes in microelectronic sensors that measure dissolved oxygen levels and monitor fouling in various liquid environments. Its products find applications in diverse sectors, including cooling systems, heat exchangers, potable and ultra-pure water, industrial boilers, and industries such as food and beverage, pharmaceuticals, pulp and paper, oil, gas, and petrochemicals. Neosens aims to enhance environmental monitoring and process efficiency through its innovative sensor technologies.

Certess

Venture Round in 2007
Certess is an electronic design automation (EDA) company that specializes in functional qualification products aimed at organizations developing and integrating complex design blocks or intellectual property (IP). Founded in 2005 and based in Campbell, California, the company addresses a critical gap in the verification process by offering tools that help design and verification engineers objectively assess and enhance the completeness of their verification environments. Despite the use of various techniques by verification teams, functional logic errors frequently lead to chip respins, underscoring the need for Certess's innovative solutions. By improving verification quality, Certess's software contributes to a more efficient and predictable integration process for system-on-chip (SoC) designs, ultimately ensuring higher quality outcomes. In March 2009, Certess was acquired by SpringSoft, LLC.

Mendel Biotechnology

Series D in 2007
Mendel Biotechnology, Inc. operates as a plant biotechnology company. The company focuses on developing genetic and chemical solutions for a range of agricultural markets. It offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company has strategic partnerships with Monsanto Corporation, BP, and Bayer CropScience. Mendel Biotechnology, Inc. was founded in 1997 and is based in Hayward, California. It has operations in the United States, Europe, and China.

MAPPER Lithography

Series B in 2007
MAPPER Lithography B.V. is a company specializing in the development of maskless lithography infrastructure for the semiconductor industry. Established in 2000 and headquartered in Delft, the Netherlands, MAPPER Lithography focuses on producing advanced lithography machines that utilize multiple electron beam technology for semiconductor manufacturing. This innovative approach allows for the production of chips without the need for traditional masks, streamlining the manufacturing process. The company also operates a manufacturing facility in Moscow, Russian Federation, further supporting its operations in the semiconductor sector.

Clear2Pay

Series D in 2006
Clear2Pay is a payments technology company that specializes in delivering innovative solutions for electronic payments processing. The company's Open Payment Framework (OPF) provides financial institutions with the ability to enhance the efficiency of their internal payment systems while offering clients improved services characterized by speed and comprehensive payment information. Clear2Pay's OPF operates within a Service-Oriented Architecture, enabling banks to process payments through a centralized engine that utilizes a library of reusable business services across various payment types. This approach allows financial institutions to integrate new service models with existing infrastructures, ensuring the protection of previous investments while transitioning to a more modern and efficient payment environment. Additionally, Clear2Pay provides a Software Development Kit and a Bank Payment Hub, which offer tools for implementing payment solutions and managing customer interactions, order execution, and dispute processing.

Gemidis

Series C in 2006
Gemidis is a spin-off company from Ghent University (Belgium) and IMEC (Belgium) and was officially founded in August 2004. Gemidis develops, produces and sells LCOS imagers and driver electronics for both consumer and professional markets.

Welcome Real Time

Venture Round in 2005
Welcome Real Time S.A. is a company that specializes in electronic payment software and services, primarily for financial institutions, payment networks, and retailers. Established in 1996 and headquartered in Aix-en-Provence, France, it offers a variety of solutions including credit and debit card acceptance, and integrated value-added services. Key products include XLS Server, which enhances EMV capabilities for payment processing systems; XLS POS, a toolkit for developing payment applications; and XLS Card, which supports card personalization and issuance. Additionally, Welcome Real Time provides CardCare for cardholder services and MerchantCare for merchant activity reporting. With research and development facilities in multiple global locations, the company focuses on creating point-of-sale customer loyalty programs and smart payment device software, along with offering maintenance and marketing consulting services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.